ELAB PMGC Holdings Inc.
Price Chart
Executive Summary
PMGC Holdings Inc. (ELAB), through its wholly owned subsidiary NorthStrive Defense Tech LLC, entered into a binding term sheet with Florida State University Research Foundation (FSURF) for an exclusive, worldwide, sublicensable license to U.S. Patent No. 12,291,334 covering 'Multi-Media Parcel Transportation Systems and Method' in the aerospace and defense field. Concurrently, NorthStrive Defense Tech funded a $490,657 educational research agreement with FSU's Center for Intelligent Systems, Control, and Robotics to develop a UAV-dragged aquatic payload proof-of-concept prototype. The license terms include tiered royalties, an annual minimum royalty, and a sublicensing revenue share, but all specific dollar amounts are redacted. For a micro-cap company pivoting from pharmaceutical preparations into defense tech, this represents a strategic pivot but with no near-term revenue and all key financial terms undisclosed.
Actionable Insight
The filing signals a strategic pivot from pharmaceuticals to defense/aerospace tech, but with no revenue, no guaranteed results, and all key financial terms redacted. Monitor for a definitive license agreement before June 30, 2026 and any subsequent funding needs — the $8M market cap suggests limited cash runway for development.
Key Facts
- NorthStrive Defense Tech LLC, a wholly owned subsidiary of PMGC Holdings Inc., entered a binding term sheet for an exclusive, worldwide, sublicensable license to U.S. Patent No. 12,291,334 in aerospace and defense technologies.
- NorthStrive Defense Tech also entered a $490,657 educational research agreement with FSU's CISCOR for a UAV-dragged aquatic payload proof-of-concept prototype, with milestone-based invoicing over 12 months.
- All specific financial terms of the license (issue fee, annual maintenance fee, royalty rates, minimum royalty, sublicense payments, patent cost reimbursement) are redacted as confidential.
- The research agreement is on a best-reasonable-efforts basis with no guaranteed results; inventions made during research belong to FSURF with a first-option for NorthStrive to negotiate a royalty-bearing license.
- The term sheet expires June 30, 2026 unless a definitive license agreement is executed by both parties.
Financial Impact
Research funding of $490,657 committed; all license financial terms (issue fee, royalties, minimums) are redacted and undisclosed.
Risk Factors
- All key financial terms of the license are redacted, making it impossible to assess dilution or cash commitment.
- The research agreement is on a best-efforts basis with no guaranteed results; inventions belong to FSU, not the company.
- The company has a history of negative stock performance on prior filings (avg T+20 return -37.6% across 8 settled reports).
- The term sheet expires June 30, 2026 — failure to execute a definitive license would void the deal.
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-065791 |
| Document: ea0293726-8k_pmgc.htm | 0001213900-26-065791 |
| Document: ea029372601ex10-1.htm | 0001213900-26-065791 |
| Document: 0001213900-26-065791-index-headers.html | 0001213900-26-065791 |
| Document: 0001213900-26-065791-index.html | 0001213900-26-065791 |
| Document: 0001213900-26-065791.txt | 0001213900-26-065791 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
6d ago
|
Press Release
| $1.52 awaiting T+5 | awaiting T+5 | — | $1.47 (−3.29%) |
|
Jun 5, 2026
9d ago
|
8-K
| $1.55 awaiting T+5 | awaiting T+5 | — | $1.47 (−5.16%) |
|
Jun 1, 2026
13d ago
|
Press Release
| $1.77 $1.54 | ▼ −12.99% | ▼ −10.24% | $1.47 (−16.95%) |
|
May 13, 2026
4w ago
|
8-K
| $1.98 $1.75 | ▼ −11.62% | ▼ −10.46% | $1.47 (−25.76%) |
|
May 13, 2026
4w ago
|
Press Release
| $1.98 $1.75 | ▼ −11.62% | ▼ −10.46% | $1.47 (−25.76%) |
|
Apr 23, 2026
7w ago
|
8-K
| $2.94 $2.53 | ▼ −13.95% | ▼ −15.42% | $1.47 (−50.00%) |
|
Apr 23, 2026
7w ago
|
Press Release
| $2.94 $2.53 | ▼ −13.95% | ▼ −15.42% | $1.47 (−50.00%) |
|
Apr 21, 2026
7w ago
|
8-K
| $3.29 $2.54 | ▼ −22.80% | ▼ −23.88% | $1.47 (−55.32%) |
|
Apr 20, 2026
7w ago
|
424B5
| $3.29 $2.54 | ▲ +22.80% | ▲ +23.88% | $1.47 (+55.32%) |
|
Apr 17, 2026
8w ago
|
8-K
| $3.28 $2.49 | ▼ −24.09% | ▼ −24.64% | $1.47 (−55.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access